Alto Neuroscience (NYSE: ANRO) net income
Alto Neuroscience reported a net loss of $63.2m for fiscal 2025; in fiscal 2024 it reported a net loss of $61.4m. Earnings per share were −$2.19.
Alto Neuroscience's best year of the last 3 was fiscal 2023. It reported a loss in 3 of those 3 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$63.2m | — | — | −$2.19 |
| 2024 | −$61.4m | — | — | −$2.50 |
| 2023 | −$36.3m | — | — | −$9.73 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Alto Neuroscience net income compared with its sector
By net income for its latest fiscal year, Alto Neuroscience ranks 280th of the 501 US health care companies with a page on Celsmar.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 278th | STLN | −$60.6m | −12.1% |
| 279th | Ardelyx | −$61.6m | −15.1% |
| 280th | Alto Neuroscience | −$63.2m | — |
| 281st | Lineage Cell Therapeutics | −$63.5m | −436.5% |
| 282nd | Simulations Plus | −$64.7m | −81.7% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Alto Neuroscience
- How much did Alto Neuroscience earn in fiscal 2025?
- Alto Neuroscience reported a net loss of $63.2m for fiscal 2025. In fiscal 2024 it reported a net loss of $61.4m.
- What are the earnings per share of Alto Neuroscience?
- They were −$2.19 in fiscal 2025, compared with −$2.50 in fiscal 2024.
- Where does Alto Neuroscience rank in its sector by net income?
- It ranks 280th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Alto Neuroscience come from?
- From the annual report (Form 10-K) that Alto Neuroscience files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Alto Neuroscience files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023. More on Alto Neuroscience: the Alto Neuroscience page · annual accounts · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.